Fractionated plasma separation and adsorption significantly decreases intracranial pressure in acute liver failure: Experimental study

European Surgical Research

Volumn 42, Issue 4, 2009, Pages 230-235

  Ryska, M ^a,b,c   Laszikova, E ^b,c   Pantoflicek, T ^a,b,c   Ryska, O ^b   Prazak, J ^a   Koblihova, E ^a,b  

^a Department of Surgery ^*  (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c CENTRAL MILITARY HOSPITAL   (Czech Republic)

Author keywords

Acute liver failure; Experimental treatment; Fractionated plasma separation and absorption

Indexed keywords

BILIRUBIN;

ADSORPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL THERAPY; FRACTIONATED PLASMA SEPARATION; HEMODYNAMIC MONITORING; HYDROCEPHALUS; INTRACRANIAL PRESSURE; LIVER FAILURE; NONHUMAN; PLASMA ADSORPTION; PLASMAPHERESIS; PRIORITY JOURNAL; RANK SUM TEST; SWINE;

ANIMALS; HEMODIAFILTRATION; INTRACRANIAL PRESSURE; LIVER FAILURE, ACUTE; SWINE;

EID: 61849088380     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000208790     Document Type: Article

References (24)

1. O'Grady J: Modern management of acute liver failure. Clin Liver Dis 2007; 11:291-303.
2. Bismuth H, Samuel D, Castaing D, et al: Orthotopic liver transplantation in fulminant and subfulminant hepatitis. Ann Surg 1995; 222: 109-119.
3. Detry O, De Roover A, Honoré P, et al: Brain edema and intracranial hypertension in fulminant failure: pathophysiology and management. World J Gastroenterol 2006; 12: 7405-7412.
4. Ryska M, Kieslichova E, Pantoflicek T, et al: Devascularization surgical model of acute liver failure in minipigs. Eur Surg Res 2004; 36:179-184.
5. Kieslichova E, Ryska M, Pantoflicek T, et al: Hemodynamic parameters in a surgical de-vascularization model of fulminant hepatic failure in the minipig. Physiol Res 2005; 54: 485-490.
6. Falkenhagen D, Strobl W, Vogt G, et al: Fractionated plasma separation and absorption system: a novel system for blood purification to remove albumin bound substance. Artif Organs 1999; 23:81-86.
7. Kramer DJ, Canabal JM, Arasi LC: Application of intensive care medicine principles in the management of acute liver failure patient. Liver Transpl 2008; 14 (suppl 2): S85-S89.
8. Steiner LA, Andrews PJD: Monitoring the injured brain: ICP and CBF. Br J Anaesth 2006; 97:26-38.
9. Williams R: The elusive goal of liver support - Quest for the Holy Grail. Clin Med 2006; 6: 482-487.
10. Phua J, Lee KH: Liver support devices. Curr Opin Crit Care 2008; 14: 208-215.
11. Stange J, Ramlow W, Mitzner S, et al: Dialysis against a recycled albumin solution enables the removal of albumin-bound toxins. Artif Organs 1993; 17:809-813.
12. Stad lbauer V, K risper P, Signet B, et al: Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure. Crit Care 2006; 10:R169.
13. Krisper P, Haditych B, Stauber R, et al: In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation. J Hepatol 2005; 43:451- 457.
14. Sen S, Rose C, Ytrebø LM, et al: Effect of albumin dialysis on intracranial pressure increase in pigs with acute liver failure. Crit Care Med 2006; 34:158-164.
15. Hassanein TI, Tofteng F, Brown RS, et al: Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology 2007; 46: 1853-1862.
16. Rifai K, Ernist T, Kretschmer U, et al: Prometheus - A new extracorporeal system for the treatment of liver failure. J Hepatol 2003; 39: 984-990.
17. Rifai K, Ernst T, Kretschmer U, et al: The Prometheus device for extracorporeal support of combined liver and renal failure. Blood Purif 2005; 23: 298-202.
18. Laleman W, Wolker A, Evenepoel P, et al: Effect of the molecular adsorbent recirculating system and Prometheus device on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit Care 2006; 10:R108.
19. Nyckowski P, Skwarek A, Zieniewicz K, et al: Orthotopic liver transplantation for fulminant hepatic failure. Transplant Proc 2006; 38:219-220.
20. Evenepoel P, Aleman W, Wolker A, et al: Detoxifying capacity and kinetics of Prometheus - a new extracorporeal system for the treatment of liver failure. Blood Purif 2005; 23:349-358.
21. Santoro A, Faenza S, Mancini E, et al: Prometheus system: a technological support in liver failure. Transplant Proc 2006; 38:1078- 1082.
22. Carraro P, Burighel D, De Silvestro G, et al: Early prognostic biochemical indicators of fulminant hepatic failure. Int J Clin Lab Res 1998; 28:196-199.
23. Rose C, Ytrebø LM, Davies NA, et al: Association of reduced extracellular brain ammonia, lactate, and intracranial pressure in pigs with acute liver failure. Hepatology 2007; 46: 1883-1892.
24. Tofreng F, Jorgensen L, Hansen BA, et al: Cerebral microdialysis in patients with fulminant hepatic failure. Hepatology 2002; 36: 1333-1340.